Wash-free, electrochemical platform for the quantitative, multiplexed detection of specific antibodies

Ryan J White1, Hannah M Kallewaard, Wen Hsieh

  • 1Department of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106-9510, United States.

Analytical Chemistry
|December 8, 2011
PubMed

Insights

A new electrochemical sensor detects specific antibodies in blood serum rapidly and quantitatively. This point-of-care diagnostic tool offers sensitive, specific results for various diseases, improving diagnostics.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Immunology

Background:

  • Accurate antibody detection is crucial for diagnosing and managing infectious and autoimmune diseases.
  • Current point-of-care diagnostics often lack the sensitivity or specificity required for comprehensive antibody analysis.
  • A need exists for rapid, direct measurement of antibodies in unprocessed biological samples.

Purpose of the Study:

  • To develop a wash-free, electrochemical method for rapid, quantitative detection of specific antibodies.
  • To demonstrate the platform's versatility and sensitivity for various antibody targets.
  • To enable simultaneous measurement of multiple antibodies in small sample volumes.

Main Methods:

  • Designed an electrochemical sensor using electrode-bound nucleic acid scaffolds with polypeptide epitopes and a methylene blue redox reporter.
  • Antibody binding to the epitope alters the redox reporter's electron exchange efficiency, generating a measurable current change.
  • Fabricated six distinct sensors for different monoclonal antibodies and tested their performance.

Main Results:

  • Achieved subnanomolar detection limits, indicating high sensitivity.
  • Demonstrated rapid detection with equilibration time constants of approximately 8 minutes.
  • Confirmed high specificity, with no significant cross-reactivity between sensors and non-target antibodies.
  • Successfully arrayed sensors for multiplexed antibody detection in small serum volumes.

Conclusions:

  • The developed sensor platform provides a generalizable approach for rapid and specific antibody quantification.
  • This technology has the potential to significantly advance point-of-care diagnostics for a range of diseases.
  • The wash-free, direct detection method simplifies sample processing and analysis.